html5-img
1 / 19

Pulmonary Metastasis From Osteosarcoma

Pulmonary Metastasis From Osteosarcoma. Multi-factorial analysis of survival at first lung involvement Ali Aljubran, Martin Blackstein for the University of Toronto Musculoskeletal Oncology Group. INTRODUCTION.

rex
Télécharger la présentation

Pulmonary Metastasis From Osteosarcoma

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Pulmonary Metastasis From Osteosarcoma Multi-factorial analysis of survival at first lung involvement Ali Aljubran, Martin Blackstein for the University of Toronto Musculoskeletal Oncology Group

  2. INTRODUCTION • The cure rate of non-metastatic cases has improved from 20% (Pre chemotherapy era) to 65%. • Recurrence still occurs in approximately 30%. • More than 80% of all relapses involve the lungs. • Complete surgical resection is the only potential curative treatment. • Single institute review.

  3. PATIENTS AND METHODS • Osteosarcoma patients (1988-2003). • Variables at the first lung involvement , e.g. RFI, multiplicity and laterality of lesions and size of the largest nodule are all analyzed. Peri operative chemotherapy was also analyzed. • Statistical methods: Post lung metastasis survival PLMS was calculated from the date of the first lung metastasis to the date of death or last follow-up.

  4. RESULTS 247 Total 1988-2003 M0 at presentation 209 (84.6%) Synchronous Mets 38 (15.4%)

  5. RESULTS 247 Total 1988-2003 No relapse 145 (69.4%) M0 at presentation 209 (84.6%) Isolated LR 8 (3.8%) Synchronous Mets 38 (15.4%) Metachronous Mets 56(26.8%) Total 94

  6. RESULTS 247 Total 1988-2003 No relapse 145 (69.4%) Med. FU 2.7y M0 at presentation 209 (84.6%) Isolated LR 8 (3.8%) Synchronous Mets 38 (15.4%) Metachronous Mets 56(26.8%) Total 94 DOD 58 (68.2%) AWED 12 (14.1%) Lung+/-others 85 Isolated Bone 9 ANED 15 (17.6%)

  7. Variables related to 1st lung involvement( only the operated cases, 47pts)..

  8. 85 patients: 3 year PLMS: 30%

  9. 3 year PLMS: Synchronous mets: 30 % Metachronous mets: 30 %

  10. 3 year PLMS: NO lung surgery: 16 % lung surgery: 38 %

  11. 3 year PLMS: 1-3 lesions: 69 %≥ 4 lesions: 18 %

  12. 3 year PLMS: Unilateral: 55 % Bilateral: 32 %

  13. 3 year PLMS: ≤ 1 cm: 67 % > 1 cm: 34 %

  14. 3 year PLMS: No chemo: 39 % Chemo: 33 %

  15. DISCUSSIONLATEST LARGE SERIES

  16. CONCLUSION • This is a large series from single center that primarily includes adult patients with median follow up of 2.7 years. • The 3 year PLMS is 30% which is comparable to previous large studies. • Surgical resection doubled the survival at 3 years. • Both Synchronous and Metachronous lung metastasis have similar survival. • Lung nodules of <4, size ≤ 1cm and unilaterality are favorable prognostic factors. • The use of chemotherapy with the resection did not appear to affect the survival.

  17. ACKNOWLEDGMENT Anthony Griffin Melania Pintilie

  18. THANK YOU

More Related